US FDA
Ask about this →0 mentions · last seen 6/5/2026
The Encyclopædia of Indian Retail — revised every hour
0 mentions · last seen 6/5/2026
The US FDA cited Dabur India's Dadra and Nagar Haveli facility for microbiological contamination risks, equipment maintenance lapses, falsified manufacturing records, and a live bird found in a raw material warehouse. The flags raise compliance concerns for the company's US-bound Ayurvedic and OTC healthcare exports.
NDTV Profit · 5/31/2026, 9:51:10 AM
A January inspection of Dabur India's Dadra and Nagar Haveli facility surfaced falsified records, a live bird in the raw material warehouse, and unreliable microbiology testing for US-exported consumer health products. The findings put Dabur's US export pipeline and quality controls under scrutiny.
Business Standard · Companies · 5/29/2026, 7:58:09 AM